Muro-Cacho CA - Search Results

1

Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression.

Diaz N, Minton S, Cox C, Bowman T, Gritsko T, Garcia R, Eweis I, Wloch M, Livingston S, Seijo E, Cantor A, Lee JH, Beam CA, Sullivan D, Jove R, Muro-Cacho CA. Diaz N, et al. Clin Cancer Res. 2006 Jan 1;12(1):20-8. doi: 10.1158/1078-0432.CCR-04-1749. Clin Cancer Res. 2006. PMID: 16397019

2

Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells.

Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M, Nam S, Eweis I, Diaz N, Sullivan D, Yoder S, Enkemann S, Eschrich S, Lee JH, Beam CA, Cheng J, Minton S, Muro-Cacho CA, Jove R. Gritsko T, et al. Clin Cancer Res. 2006 Jan 1;12(1):11-9. doi: 10.1158/1078-0432.CCR-04-1752. Clin Cancer Res. 2006. PMID: 16397018

3

Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells.

Mora LB, Buettner R, Seigne J, Diaz J, Ahmad N, Garcia R, Bowman T, Falcone R, Fairclough R, Cantor A, Muro-Cacho C, Livingston S, Karras J, Pow-Sang J, Jove R. Mora LB, et al. Cancer Res. 2002 Nov 15;62(22):6659-66. Cancer Res. 2002. PMID: 12438264

4

Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.

Garcia R, Bowman TL, Niu G, Yu H, Minton S, Muro-Cacho CA, Cox CE, Falcone R, Fairclough R, Parsons S, Laudano A, Gazit A, Levitzki A, Kraker A, Jove R. Garcia R, et al. Oncogene. 2001 May 3;20(20):2499-513. doi: 10.1038/sj.onc.1204349. Oncogene. 2001. PMID: 11420660

5

Dasatinib inhibits migration and invasion in diverse human sarcoma cell lines and induces apoptosis in bone sarcoma cells dependent on SRC kinase for survival.

Shor AC, Keschman EA, Lee FY, Muro-Cacho C, Letson GD, Trent JC, Pledger WJ, Jove R. Shor AC, et al. Cancer Res. 2007 Mar 15;67(6):2800-8. doi: 10.1158/0008-5472.CAN-06-3469. Cancer Res. 2007. PMID: 17363602

6

Expression of TGFbeta type-II receptor in association with markers of proliferation and apoptosis in premalignant lung lesions.

Muñoz-Antonia T, Muro-Cacho C, Sharma S, Cantor A, Bepler G. Muñoz-Antonia T, et al. Cancer. 2007 Oct 1;110(7):1527-31. doi: 10.1002/cncr.22937. Cancer. 2007. PMID: 17676583 Free article.

7

Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2.

Muro-Cacho CA, Rosario-Ortiz K, Livingston S, Muñoz-Antonia T. Muro-Cacho CA, et al. Clin Cancer Res. 2001 Jun;7(6):1618-26. Clin Cancer Res. 2001. PMID: 11410498

8

Prognostic factors in malignant gastrointestinal stromal tumors.

Muro-Cacho CA, Cantor AB, Morgan M. Muro-Cacho CA, et al. Ann Clin Lab Sci. 2000 Jul;30(3):239-47. Ann Clin Lab Sci. 2000. PMID: 10945563

9

Transforming growth factor beta receptors and p27kip in thyroid carcinoma.

Muro-Cacho CA, Muñoz-Antonia T, Livingston S, Klotch D. Muro-Cacho CA, et al. Arch Otolaryngol Head Neck Surg. 1999 Jan;125(1):76-81. doi: 10.1001/archotol.125.1.76. Arch Otolaryngol Head Neck Surg. 1999. PMID: 9932593

10

Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck squamous cell carcinoma.

Báez A, Cantor A, Fonseca S, Marcos-Martinez M, Mathews LA, Muro-Cacho CA, Muñoz-Antonia T. Báez A, et al. Clin Cancer Res. 2005 May 1;11(9):3191-7. doi: 10.1158/1078-0432.CCR-04-1299. Clin Cancer Res. 2005. PMID: 15867212

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters